1. Alpert M, Friedhoff AJ, Diamond F (1983) Use of dopamine receptor agonists to reduce dopamine receptor number as treatment for tardive dyskinesia. In: Fahn S, Calne DB, Shoulson I (eds) Experimental therapeutics of movement disorders. Raven, New York, pp 253–266
2. Brandrup E (1961) Tetrabenazine treatment in persisting dyskinesia caused by psychopharmaca. Am J Psychiatry 118: 551–552
3. Bruun RD (1982) Dysphoric phenomena associated with haloperidol treatment of Tourette syndrome. In: Friedhoff AJ, Chase TN (eds) Gilles de la Tourette syndrome. Raven, New York, pp 433–436
4. Carlsson A, Lundquist M, Magnusson T (1967) 3,4-dehydroxyphenalanine and 5-hydrox- tryptophan as reserpine antagonists. Nature 180: 1200
5. Chien CP (1980) Tardive dyskinesia: controlled studies of several therapeutic agents. In: Fann WE, Smith RC, Davis JM, Domino EF (eds) Tardive dyskinesia. Spectrum, New York, pp 429–469